SGH Announces CFO Transition Plan
Jack Pacheco, SGH COO and Former CFO, to Serve as Interim CFO Reiterates Financial Guidance Provided on April 9, 2024 MILPITAS, Calif.–(BUSINESS WIRE)–$SGH... Read more.
AEye Reports First Quarter 2024 Results
Kicked off key strategic partnership that will bring AEye’s lidar into the China market Fourth consecutive quarter of cash burn reduction DUBLIN, Calif.–(BUSINESS... Read more.
Nu Skin Releases 2023 Social Impact and Sustainability Report
Report highlights the beauty and wellness brand’s global social impact and sustainability achievements PROVO, Utah–(BUSINESS WIRE)–Nu Skin, a global... Read more.
Procaps Group Delays Filing of Annual Report on Form 20-F
MIAMI & BARRANQUILLA, Colombia–(BUSINESS WIRE)–Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare... Read more.
Intellinetics Grows 2024 First Quarter Revenues 7.7%, Grows SaaS Revenue 13.5%
COLUMBUS, Ohio–(BUSINESS WIRE)–Intellinetics, Inc. (NYSE American: INLX), a digital transformation solutions provider, announced financial results for... Read more.
DermTech Reports First-Quarter 2024 Financial Results
– Average selling price (ASP) for the DermTech Melanoma Test (DMT) increased 24 percent year-over-year – Test revenue increased 7 percent versus the... Read more.
Nextracker Reports Q4 and FY24 Financial Results
Achieves Record Revenue and Profits First U.S. Solar Company to Achieve 100 Gigawatts Global Shipment Milestone FREMONT, Calif.–(BUSINESS WIRE)–Nextracker... Read more.
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Acquisition of AnHeart Therapeutics transformed Nuvation Bio into a late-stage, global oncology company with potential to become a commercial organization by the... Read more.
Energous Corporation Reports 2024 First Quarter Results
SAN JOSE, Calif.–(BUSINESS WIRE)–Energous Corporation (NASDAQ: WATT), a leading developer of RF-based intelligent wireless power networks, today announced... Read more.
Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization... Read more.